Eagle Pharmaceuticals shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17k | 3.2k | 5.24 |
| 2023-09-30 | $42k | 2.6k | 15.77 |
| 2023-06-30 | $78k | 4.0k | 19.44 |
| 2022-12-31 | $14k | 484 | 29.23 |
| 2022-09-30 | $31k | 1.1k | 26.92 |
| 2022-06-30 | $47k | 1.1k | 42.45 |
| 2022-03-31 | $2.1M | 42k | 49.48 |
| 2021-12-31 | $2.2M | 44k | 50.92 |
| 2021-09-30 | $0 | 264k | 0.00 |
| 2021-06-30 | $7.4M | 174k | 42.81 |
| 2021-03-31 | $2.2M | 53k | 41.73 |
| 2020-12-31 | $2.1M | 45k | 46.57 |
| 2020-09-30 | $1.4M | 34k | 42.50 |
| 2020-06-30 | $1.6M | 34k | 47.97 |
| 2020-03-31 | $1.5M | 32k | 46.02 |
| 2019-12-31 | $2.1M | 35k | 60.09 |
| 2019-09-30 | $1.9M | 34k | 56.57 |
| 2019-06-30 | $1.6M | 28k | 55.69 |
| 2019-03-31 | $1.3M | 25k | 50.50 |
| 2018-12-31 | $920k | 23k | 40.23 |
| 2018-09-30 | $1.3M | 19k | 69.34 |
| 2018-06-30 | $1.7M | 23k | 75.72 |
| 2018-03-31 | $1.2M | 23k | 52.72 |
| 2017-12-31 | $1.1M | 20k | 53.43 |
| 2017-06-30 | $1.3M | 16k | 78.82 |
| 2017-03-31 | $1.1M | 13k | 82.87 |
| 2016-12-31 | $1.4M | 18k | 79.28 |
| 2016-09-30 | $446k | 6.4k | 70.00 |
| 2016-06-30 | $143k | 3.7k | 38.92 |
| 2016-03-31 | $145k | 3.6k | 40.63 |
| 2015-12-31 | $886k | 10k | 88.72 |
| 2015-09-30 | $1.4M | 19k | 74.17 |
| 2015-03-31 | $161k | 3.9k | 41.80 |
| 2014-12-31 | $130k | 8.4k | 15.46 |
| 2014-06-30 | $7.0k | 500 | 14.00 |
| 2014-03-31 | $10k | 800 | 12.50 |